Data Sheet 1_Alleviating psychosocial distress in drug-resistant tuberculosis: a pre-post

Fanghui Xie's pilot study data evaluates a 12-week telephone-delivered motivational interviewing intervention for 74 drug-resistant tuberculosis patients in Chengdu, China, during 2021. The dataset likely contains pre- and post-intervention psychological assessments measuring loneliness, depression, anxiety, sleep quality, and medication adherence. Results show significant reductions in loneliness, anxiety, and depressive symptoms among participants.

Use Cases

• Analyze the efficacy of telephone-delivered motivational interviewing based on pre-post changes in psychological scale scores.
• Study correlations between psychosocial distress and medication adherence in drug-resistant tuberculosis patients based on the described binary adherence outcome.
• Evaluate the impact of a mental health intervention on sleep quality based on Pittsburgh Sleep Quality Index (PSQI) scores mentioned in the results.

Strengths

• Data is associated with a specific clinical study involving 74 patients, providing a defined sample size.
• Results show statistically significant improvements (p<0.001) in loneliness, depression, anxiety, and sleep quality, indicating measurable outcomes.
• The dataset is openly licensed under CC-BY-4.0, facilitating reuse and sharing.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for certain analyses.
• The study uses a single-group pre-post design without a control group, which may limit causal inference as noted in the conclusion.

Provenance

Source

Fanghui Xie via figshare.

Collection Method

Single-group pre-post study with assessments at baseline and post-intervention.

Time Range

Data collected between January and December 2021.

Freshness

Last updated 2026-05 08 05:46:49; freshness should be verified.

Geography

Patients recruited from the tuberculosis wards of Chengdu Public Health Clinical Medical Center in China.